Iragorri N - Search Results

1

The cost of failed first-line cancer treatment related to continued smoking in Canada.

Iragorri N, Essue B, Timmings C, Keen D, Bryant H, Warren GW. Iragorri N, et al. Curr Oncol. 2020 Dec;27(6):307-312. doi: 10.3747/co.27.5951. Epub 2020 Dec 1. Curr Oncol. 2020. PMID: 33380862 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 33704203

3

The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Iragorri N, de Oliveira C, Fitzgerald N, Essue B. Iragorri N, et al. Curr Oncol. 2021 Mar 15;28(2):1216-1248. doi: 10.3390/curroncol28020117. Curr Oncol. 2021. PMID: 33804288 Free PMC article. Review.

4

The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.

Iragorri N, de Oliveira C, Fitzgerald N, Essue B. Iragorri N, et al. Appl Health Econ Health Policy. 2021 May;19(3):325-341. doi: 10.1007/s40258-020-00619-z. Epub 2020 Dec 24. Appl Health Econ Health Policy. 2021. PMID: 33368032 Free PMC article.

5

The psychosocial cost burden of cancer: A systematic literature review.

Essue BM, Iragorri N, Fitzgerald N, de Oliveira C. Essue BM, et al. Among authors: iragorri n. Psychooncology. 2020 Nov;29(11):1746-1760. doi: 10.1002/pon.5516. Epub 2020 Sep 6. Psychooncology. 2020. PMID: 32783287 Free PMC article.

6

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.

de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse EFP, Lew JB, Greuter MJE, Smith HA, Feletto E, Yong JHE, Canfell K, Coupé VMH, Lansdorp-Vogelaar I; COVID-19 and Cancer Global Modelling Consortium working group 2. de Jonge L, et al. Among authors: iragorri n. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. doi: 10.1016/S2468-1253(21)00003-0. Epub 2021 Feb 3. Lancet Gastroenterol Hepatol. 2021. PMID: 33548185 Free PMC article.

7

The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.

Yong JH, Mainprize JG, Yaffe MJ, Ruan Y, Poirier AE, Coldman A, Nadeau C, Iragorri N, Hilsden RJ, Brenner DR. Yong JH, et al. Among authors: iragorri n. J Med Screen. 2021 Jun;28(2):100-107. doi: 10.1177/0969141320974711. Epub 2020 Nov 26. J Med Screen. 2021. PMID: 33241760 Free PMC article.

8

Model to Determine the Cost-Effectiveness of Screening Psoriasis Patients for Psoriatic Arthritis.

Iragorri N, Hazlewood G, Manns B, Bojke L, Spackman E; Early Detection to Improve Outcome in People With Undiagnosed Psoriatic Arthritis Study Group. Iragorri N, et al. Arthritis Care Res (Hoboken). 2021 Feb;73(2):266-274. doi: 10.1002/acr.24110. Arthritis Care Res (Hoboken). 2021. PMID: 31733035

9

Cost Effectiveness of Treatments for Chronic Constipation: A Systematic Review.

Han D, Iragorri N, Clement F, Lorenzetti D, Spackman E. Han D, et al. Among authors: iragorri n. Pharmacoeconomics. 2018 Apr;36(4):435-449. doi: 10.1007/s40273-018-0609-6. Pharmacoeconomics. 2018. PMID: 29352437

10

Psoriatic arthritis screening: a systematic review and meta-analysis.

Iragorri N, Hazlewood G, Manns B, Danthurebandara V, Spackman E. Iragorri N, et al. Rheumatology (Oxford). 2019 Apr 1;58(4):692-707. doi: 10.1093/rheumatology/key314. Rheumatology (Oxford). 2019. PMID: 30380111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page